Scientists created a stem cell-based method to produce high-quality mitochondria at scale, enabling effective treatments for ...

The board of directors of Grayson-Jockey Club Research Foundation announced that it has authorized expenditure of $2,693,312 ...

The board of directors of Grayson-Jockey Club Research Foundation announced that it has authorized expenditures of $2,693,312 ...

Terumo Blood and Cell Technologies has entered into a memorandum of understanding (MOU) with South Korea’s KBIOHealth to jointly develop workforce training initiatives aimed at enhancing cell ...

A study conducted by Prof. Thai-Yen Ling at National Taiwan University underscores the potential of small extracellular ...

The following is a summary of “A Novel Molecular Regulatory Network in Bone Marrow Mesenchymal Stem Cells for Age-Related Osteoporosis,” published in the March 2025 issue of Clinical Endocrinology by ...

Mesoblast’s RYONCIL ® (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA approved mesenchymal ...

Aged individuals and astronauts experience bone loss despite rigorous physical activity. Bone mechanoresponse is in-part ...

Scientists have unveiled a revolutionary method for mass-producing high-quality human mitochondria, potentially transforming ...

Q4 2024 Earnings Call Transcript March 27, 2025 BioRestorative Therapies, Inc. beats earnings expectations. Reported EPS is $ ...

Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

A revolutionary case study and scientific research have revealed that INDIBA 448 kHz monopolar radiofrequency technology ...